Compare Adaptive Biotechnologies Corp (ADPT) vs Extra Space Storage, Inc. (EXR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Adaptive Biotechnologies Corp vs Extra Space Storage, Inc. — how do they compare? Adaptive Biotechnologies Corp trades at $25.09 (market cap $4.04B), while Extra Space Storage, Inc. trades at $146.75 (market cap $30.96B). The key difference: Extra Space Storage, Inc. is far larger — about 7.7× Adaptive Biotechnologies Corp's market cap, and Extra Space Storage, Inc. pays a 4.42% dividend while Adaptive Biotechnologies Corp pays none. Which is the better fit depends on your goals.
| ADPT | EXR | |
|---|---|---|
Market Cap | $4.04B | $30.96B |
Sector | Health | Real Estate |
52-Week High | $25.45 | $152.85 |
52-Week Low | $12.30 | $126.67 |
Enterprise Value | $4.10B | $44.68B |
Dividend Yield | — | 4.42% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ADPT trades at $24.94, down 2.0% today but near its 52-week high. The stock shows a bullish technical trend with improving fundamentals, including 49% MRD revenue growth and narrowing losses. A recent 4:1 reverse stock split and planned business separation aim to unlock value, with analyst consensus leaning bullish.
Outlook is cautiously optimistic due to strong revenue growth and margin expansion, but risks persist from ongoing net losses and competitive pressures. The stock offers potential upside to the $25.50 consensus target if execution continues improving, yet volatility may remain until profitability is achieved.
EXR trades at $147.22, up 0.38% today, near its 52-week high with a consensus price target of $157.25. The stock shows strong fundamentals, with Q2 2026 EPS beating estimates and a dividend yield supported by robust cash flow. Technicals are bearish on moving averages but neutral on oscillators, with key resistance at $148. Revenue growth has been steady, and the company maintains high profitability margins.
Outlook is positive with consistent earnings beats and a solid balance sheet, though high valuation multiples and competitive pressures pose risks. Analysts are mixed with a 'Hold' consensus, but institutional interest remains strong. The stock offers growth potential but requires monitoring of debt levels and market sentiment shifts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Adaptive Biotechnologies Corp
Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
Read more on ADPT →About Extra Space Storage, Inc.
Extra Space Storage is a fully integrated real estate investment trust that owns, operates, and manages almost 2,100 self-storage properties in 41 states, with over 160 million net rentable square feet of storage space. Of these properties, approximately one half is wholly owned, while some facilities are owned through joint ventures and others are owned by third parties and managed by Extra Space Storage in exchange for a management fee.
Read more on EXR →
